0 Commentarii
0 Distribuiri
66 Views
0 previzualizare
Sponsor
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Cancer & Infectious Disease Focus Fuels Adjuvant R&D BoomValued at US $3.81 billion in 2024, the Vaccine Adjuvants Market is gaining prominence in global health. With a projected CAGR of 4.3%, the market is on track to reach US $4.86 billion by 2030, powered by advancements in vaccine technologies and a growing emphasis on public immunization. View the Executive Summary Free Market Drivers & Growth Catalysts 1. Rising Infectious Disease...0 Commentarii 0 Distribuiri 106 Views 0 previzualizare
Sponsor